To add content to items, click on the ‘Add/Edit Content’ link.
The Residency Training Program within the Division of Urology at the University of Colorado School of Medicine is a fully accredited four year program comprised of two (2) residents per year. A prerequisite of two years of General Surgery is required and it is expected that residents complete this requirement at the University of Colorado.
The educational philosophy of the program is to provide the best possible resident training in urology. To achieve this, the goals for urology resident training are:
•To provide adequate volume and variety of surgical experience in general urology and the various urologic subspecialties. This includes urologic cancer, geriatric urology, female urology and urodynamics, neurourology, pediatric urology, infertility and impotence, erectile dysfunction, endourology and stone disease, laparoscopy, renovascular disease, infectious disease and genitourinary trauma.
To provide adequate ambulatory experience (outpatient clinical experience) in general urology and various urologic subspecialties as listed above.
To provide educational and research conferences to further enhance the training experience. These conferences should cover the basic sciences as they relate to urologic physiology and pathology, urologic imaging, combined morbidity and mortality conferences for all participating institutions, urological pathology, journal reviews, and other subjects having educational value in the basic and clinical domains of urology.
Participating institutions are selected for the ability to provide unique experience and the necessary volume and variety of cases for optimal resident training. All the participating institutions are within an 8-mile radius of the sponsoring institution, allowing for resident interaction and combined conference participation at least twice per week.
The Division of Urology has advanced its research efforts through the development of an NIH-funded basic research laboratory that is housed in the Research 2 Building on the Anschutz Medical Campus of the University of Colorado. Directed by Hari K. Koul, PhD this core facility will provide a pivotal resource for basic research in pediatric urology, voiding dysfunction, urinary stone disease, erectile dysfunction, urologic oncology, and minimally invasive approaches to urologic surgery.
Prior to his arrival at the CU School of Medicine, Dr. Koul was chief of the Signal Transduction Laboratory at the Vattikuti Urology Institute at Henry Ford Health Systems in Detroit, MI.
The goal of this laboratory is to understand the molecular mechanisms involved in pathologic conditions associated with the urogenital tract. A specific focus of the various studies is to understand the role of mitogen activated protein (MAP) kinase signal transduction pathways in development, physiology and pathophysiology of the urogenital system.